Gov’t Approves Use of HIV injectables in Uganda
Uganda’s National Drug Authority (NDA) has approved the use of lenacapavir, a twice-yearly HIV prevention (PrEP) injection manufactured by Gilead Sciences, a U.S.-based company. The approval is a game-changer for HIV prevention, especially for people at high risk of infection. It marks a significant step toward ending AIDS by 2030.
Quality Chemicals Secures USD 36 Million Facility to Expand Production of Life-Saving Medicine
Quality Chemical Industries Limited (Qcil) has secured a USD 36 million (UGX 133 billion) debt facility from Stanbic Bank Uganda to construct a second manufacturing facility. This new facility will not only increase production capacity for Qcil’s existing portfolio, but also enable the company to expand into new therapeutic areas,
